Published in EMBO J on January 03, 1995
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Subunit compositions of the RNA-silencing enzymes Pol IV and Pol V reveal their origins as specialized forms of RNA polymerase II. Mol Cell (2008) 2.43
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol (1996) 1.89
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol (2002) 1.78
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol (2001) 1.59
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Characterization of human RNA polymerase III identifies orthologues for Saccharomyces cerevisiae RNA polymerase III subunits. Mol Cell Biol (2002) 1.55
The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A (1997) 1.46
PolV(PolIVb) function in RNA-directed DNA methylation requires the conserved active site and an additional plant-specific subunit. Proc Natl Acad Sci U S A (2009) 1.43
Four subunits that are shared by the three classes of RNA polymerase are functionally interchangeable between Homo sapiens and Saccharomyces cerevisiae. Mol Cell Biol (1995) 1.43
The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol (2005) 1.43
RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol (1998) 1.39
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol (1996) 1.35
The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol Cell Biol (1995) 1.32
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest (2001) 1.27
Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol (1998) 1.26
Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol (1997) 1.25
pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J (1996) 1.24
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci U S A (1996) 1.19
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci U S A (1996) 1.18
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol (2004) 1.15
Six human RNA polymerase subunits functionally substitute for their yeast counterparts. Mol Cell Biol (1995) 1.15
RNA polymerase subunit RPB5 plays a role in transcriptional activation. Proc Natl Acad Sci U S A (1998) 1.10
Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol (2001) 1.08
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res (1996) 1.07
Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia (2002) 1.06
TATA-Binding protein-interacting protein 120, TIP120, stimulates three classes of eukaryotic transcription via a unique mechanism. Mol Cell Biol (1999) 1.06
BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10alpha in activated transcription. Proc Natl Acad Sci U S A (2000) 1.06
Host cell-virus cross talk: phosphorylation of a hepatitis B virus envelope protein mediates intracellular signaling. J Virol (1998) 1.03
Crystal structure of RPB5, a universal eukaryotic RNA polymerase subunit and transcription factor interaction target. Proc Natl Acad Sci U S A (2000) 1.03
RPB5-mediating protein is required for the proliferation of hepatocellular carcinoma cells. J Biol Chem (2011) 1.03
Subcellular localization of RPB5-mediating protein and its putative functional partner. Mol Cell Biol (2004) 1.02
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway. EMBO J (1998) 1.01
Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology (2007) 0.99
Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res (2006) 0.98
Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J Biol Chem (2009) 0.96
Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med Mol Morphol (2009) 0.93
Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners. J Virol (2006) 0.92
HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int (2013) 0.92
RNA polymerase I-specific subunit CAST/hPAF49 has a role in the activation of transcription by upstream binding factor. Mol Cell Biol (2006) 0.91
pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants. Genes Dev (1998) 0.91
Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework. J Virol (1998) 0.90
Rpo26p, a subunit common to yeast RNA polymerases, is essential for the assembly of RNA polymerases I and II and for the stability of the largest subunits of these enzymes. Mol Cell Biol (1996) 0.90
Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression. J Virol (2000) 0.89
Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. J Virol (2006) 0.85
Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. World J Gastroenterol (2001) 0.84
Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver. World J Gastroenterol (2001) 0.83
HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells. BMC Cancer (2015) 0.83
RMP plays distinct roles in the proliferation of hepatocellular carcinoma cells and normal hepatic cells. Int J Biol Sci (2013) 0.83
Involvement of multiple subunit-subunit contacts in the assembly of RNA polymerase II. Nucleic Acids Res (2000) 0.82
Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol (2011) 0.82
Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Int J Endocrinol (2015) 0.80
The viral oncoprotein HBx of Hepatitis B virus promotes the growth of hepatocellular carcinoma through cooperating with the cellular oncoprotein RMP. Int J Biol Sci (2014) 0.79
Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia (2003) 0.79
Cloning, soluble expression, and purification of the RNA polymerase II subunit RPB5 from Saccharomyces cerevisiae. Bioengineered (2015) 0.78
Cytochrome C oxidase III interacts with hepatitis B virus X protein in vivo by yeast two-hybrid system. World J Gastroenterol (2004) 0.78
RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma. Oncotarget (2015) 0.77
Comparison of inter- and intraspecies variation in humans and fruit flies. Genom Data (2014) 0.77
Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx. Proc Natl Acad Sci U S A (2016) 0.76
The mitogenic function of hepatitis B virus X protein resides within amino acids 51 to 140 and is modulated by N- and C-terminal regulatory regions. J Virol (2006) 0.76
Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma. Int J Biol Sci (2016) 0.75
Activation of a chimeric Rpb5/RpoH subunit using library selection. PLoS One (2014) 0.75
Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells. Hepat Mon (2013) 0.75
Hepatitis B virus X protein in liver tumor microenvironment. Tumour Biol (2016) 0.75
RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model. Jundishapur J Microbiol (2015) 0.75
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
The hepatitis B virus. Nature (1985) 8.71
A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science (1993) 7.42
An RNA polymerase II holoenzyme responsive to activators. Nature (1994) 6.22
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
RNA polymerase II. Annu Rev Biochem (1991) 3.86
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Role of the RNA polymerase alpha subunit in transcription activation. Mol Microbiol (1992) 2.37
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol (1985) 2.24
Subunits shared by eukaryotic nuclear RNA polymerases. Genes Dev (1990) 2.09
Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A (1993) 2.06
Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol (1992) 2.04
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem (1991) 1.84
Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A (1989) 1.77
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J (1990) 1.54
Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology (1993) 1.50
Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene (1992) 1.38
The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene (1990) 1.21
Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem (1994) 1.21
Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function. Virology (1993) 1.15
Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. Nucleic Acids Res (1989) 1.12
X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn J Cancer Res (1990) 1.07
Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology (1994) 1.07
Isolation and molecular characterization of a cDNA encoding the 23-kDa subunit of human RNA polymerase II. J Biol Chem (1989) 1.01
The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene (1993) 0.99
Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci U S A (1992) 0.96
Multiple simian virus 40 enhancer elements mediate the trans-activating function of the X protein of hepatitis B virus. Virology (1991) 0.81
Hepadnavirus enhancer and its binding proteins. Gastroenterol Jpn (1990) 0.81
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Regulation of PTEN transcription by p53. Mol Cell (2001) 5.44
Circulating activated endothelial cells in sickle cell anemia. N Engl J Med (1997) 5.13
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior. Am J Community Psychol (1999) 3.98
A low copy number central sequence with strict symmetry and unusual chromatin structure in fission yeast centromere. Mol Biol Cell (1992) 3.94
Composite motifs and repeat symmetry in S. pombe centromeres: direct analysis by integration of NotI restriction sites. Cell (1989) 3.46
Control of pollen tube tip growth by a Rop GTPase-dependent pathway that leads to tip-localized calcium influx. Plant Cell (1999) 3.32
Understanding the clinical dilemmas that shape medical students' ethical development: questionnaire survey and focus group study. BMJ (2001) 3.23
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene (2006) 3.18
Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17
Tannins and human health: a review. Crit Rev Food Sci Nutr (1998) 3.03
The action of proteolytic enzymes on N,N-dimethyl proteins. Basis for a microassay for proteolytic enzymes. J Biol Chem (1969) 2.94
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity (2000) 2.93
Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol (2000) 2.61
Observations on Australia antigen in Japanese. Vox Sang (1968) 2.57
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54
Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol (2000) 2.49
Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol (2000) 2.49
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol (1999) 2.46
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Role of the unfolded protein response in cell death. Apoptosis (2006) 2.39
Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37
The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem (1998) 2.29
Passive smoking and lung cancer. Lancet (1983) 2.27
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol (1985) 2.24
Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med (1998) 2.19
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis (2011) 2.19
Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci (2001) 2.19
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol (2000) 2.11
Detection of serum hepatitis C virus RNA. Lancet (1990) 2.05
Magnetic resonance elastography of brain tumors: preliminary results. Acta Radiol (2007) 2.04
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels. J Biol Chem (2001) 1.99
The Rop GTPase switch controls multiple developmental processes in Arabidopsis. Plant Physiol (2001) 1.93
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res (2010) 1.92
Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg (2006) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem (1991) 1.84
Polymer-assisted deposition of metal-oxide films. Nat Mater (2004) 1.83
The role of cations in the organization of chloroplast membranes. Arch Biochem Biophys (1971) 1.82
Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg (1997) 1.79
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012) 1.73
Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med (2000) 1.72
Light-induced changes in the conformation and configuration of the thylakoid membrane of Ulva and Porphyra chloroplasts in vivo. Plant Physiol (1970) 1.71
Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res (2000) 1.69
Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol (2001) 1.67
A common position-dependent mechanism controls cell-type patterning and GLABRA2 regulation in the root and hypocotyl epidermis of Arabidopsis. Plant Physiol (1998) 1.67
The unc-18 gene encodes a novel protein affecting the kinetics of acetylcholine metabolism in the nematode Caenorhabditis elegans. J Neurochem (1992) 1.65
Analysis of demand conditions associated with stereotypy. J Behav Ther Exp Psychiatry (1987) 1.61
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61
Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc Natl Acad Sci U S A (2000) 1.60
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol (1999) 1.58
Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res (1998) 1.52
Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J Gen Virol (2002) 1.52
Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem (1997) 1.52
Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol (2013) 1.49
Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer (1995) 1.48
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol (1999) 1.48
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Proton NMR and structural features of a 24-nucleotide RNA hairpin. Biochemistry (1995) 1.47
Molecular cloning and characterization of winter flounder antifreeze cDNA. Proc Natl Acad Sci U S A (1981) 1.47
Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology (1996) 1.46
CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci (2008) 1.46
Hypothesis: interventions that increase the response to stress offer the potential for effective life prolongation and increased health. J Gerontol A Biol Sci Med Sci (1996) 1.44
Generation of multiple electrosprays using microfabricated emitter arrays for improved mass spectrometric sensitivity. Anal Chem (2001) 1.44
Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease. J Inherit Metab Dis (2002) 1.43
Decreased circulation time in the upper limb reduces the lag time of the finger pulse oximeter response. Can J Anaesth (1992) 1.43
Temporal bone fractures inducing facial nerve paralysis: a new classification and its clinical significance. Ear Nose Throat J (1997) 1.42
Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol (1983) 1.39
RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol (1998) 1.39
Effects of epidural anesthesia on cardiovascular response and survival in experimental hemorrhagic shock in dogs. Anesthesiology (1989) 1.38
The binding database: overview and user's guide. Biopolymers (2002) 1.38
Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther (2000) 1.37
Response tuning in bacterial chemotaxis. Proc Natl Acad Sci U S A (1999) 1.37
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem (2001) 1.36
c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ (2007) 1.36
Structure of a peptide antifreeze and mechanism of adsorption to ice. Biochim Biophys Acta (1977) 1.35
Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology (1994) 1.35
The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol Cell Biol (2001) 1.35
Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol (1988) 1.34
Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity. Mol Cell Biol (2001) 1.32
Retinal remodeling. Jpn J Ophthalmol (2012) 1.32
A large number of tRNA genes are symmetrically located in fission yeast centromeres. J Mol Biol (1991) 1.32
Expression of Sprouty genes 1, 2 and 4 during mouse organogenesis. Mech Dev (2001) 1.31
Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice. J Neurosci (2001) 1.29
Ataxic hemiparesis with trigeminal weakness. Neurology (1981) 1.29
Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol (1999) 1.28
Gerontogenes mediate health and longevity in nematodes through increasing resistance to environmental toxins and stressors. Exp Gerontol (2000) 1.28
Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol (2001) 1.27
Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal Biochem (2001) 1.27